BioNTech to acquire Neon Therapeutics Acquisitions, Bioinformatics, Biotechnology, Business, CAR-T Therapy, Immunotherapies, Oncogenes, Product Pipelines BioNTech will acquire Neon Therapeutics Inc. in an all-stock transaction valued at approximately $67 million. Read more January 16, 2020/by GlobeNewswire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 GlobeNewswire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png GlobeNewswire2020-01-16 07:30:312020-01-16 15:50:38BioNTech to acquire Neon Therapeutics
